Fayed Nirmeen A, Abo El-Wafa Hatem B, Gab-Alla Nahla M, Yassen Khaled A, Lotfy Mamdouh E
Middle East J Anaesthesiol. 2014 Jun;22(5):467-76.
Postoperative pain is one of the most important problems that confront surgical patients. The aim of this work is to compare pain control using intravenous patient controlled analgesia (PCA) and patient controlled epidural analgesia (PCEA) in cirrhotic patients undergoing elective hepatic resection.
Thirty four adult patients ASAI and II scheduled for liver resection were randomly allocated into two groups-Group (P) with I.V (PCA) with fentanyl and Group (E) (PCEA) via epidural catheter using Bubivacaine 0.125% plus 2 microgram per ml fentanyl. Coagulation changes were followed and pain score was compared in both groups.
34 child A cirrhotic patients, undergoing liver resection were studied. The demographic data were comparable in both groups. There was a significant decrease in pain score in both groups during the follow up period when compared to their initial score. When comparing average pain score between both groups, the PCEA group had significantly lower values. The changes in prothrombin time (PT), INR, and hemoglobin (Hb), were significant all over the follow up period compared to their corresponding base line values. 2 cases needed FFP to normalize the INR for epidural removal. There was no significant difference regarding postoperative nausea and vomiting (PONV) in both groups, no clinical manifestation suggesting epidural hematoma, and no cases were recorded to have respiratory depression. There were no significant differences in patient satisfaction and ICU stay.
The two modalities of pain control seems to be nearly equivalent, but considering the risk of epidural catheter insertion and removal in cirrhotic patients who are further exposed to hepatectomy with subsequent additional coagulopathy, it may be wise to consider IVPCA technique as a policy for pain management in cirrhotic patient undergoing hepatectomy.
术后疼痛是外科患者面临的最重要问题之一。本研究的目的是比较静脉自控镇痛(PCA)和自控硬膜外镇痛(PCEA)在择期肝切除的肝硬化患者中的疼痛控制效果。
34例计划行肝切除的成年ASA I级和II级患者被随机分为两组——使用芬太尼静脉PCA的P组和使用0.125%布比卡因加每毫升2微克芬太尼经硬膜外导管行PCEA的E组。随访两组的凝血变化并比较疼痛评分。
研究了34例接受肝切除的Child A级肝硬化患者。两组的人口统计学数据具有可比性。与初始评分相比,两组在随访期间疼痛评分均显著降低。比较两组的平均疼痛评分时,PCEA组的值显著更低。与相应的基线值相比,随访期间凝血酶原时间(PT)、国际标准化比值(INR)和血红蛋白(Hb)的变化均显著。2例患者需要输注新鲜冰冻血浆以使INR正常化以便拔除硬膜外导管。两组术后恶心呕吐(PONV)无显著差异,无提示硬膜外血肿的临床表现,也无呼吸抑制病例记录。患者满意度和重症监护病房停留时间无显著差异。
两种疼痛控制方式似乎几乎等效,但考虑到肝硬化患者插入和拔除硬膜外导管的风险,且这些患者进一步接受肝切除,随后会出现额外的凝血病,对于接受肝切除的肝硬化患者,将静脉PCA技术作为疼痛管理策略可能是明智的。